Cargando…
Effect of adjuvant radioactive iodine therapy on survival in rare oxyphilic subtype of thyroid cancer (Hürthle cell carcinoma)
PURPOSE: Radioactive iodine (RAI) is widely used for adjuvant therapy after thyroidectomy, while its value for thyroid cancer has been controversial recently. The primary objectives of this study were to clarify the influence of Radioactive iodine (RAI) on the survival in rare oxyphilic subtype of t...
Autores principales: | Yang, Qiong, Zhao, Zhongsheng, Zhong, Guansheng, Jin, Aixiang, Yu, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716497/ https://www.ncbi.nlm.nih.gov/pubmed/31523497 http://dx.doi.org/10.7717/peerj.7458 |
Ejemplares similares
-
Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hurthle cell carcinoma)
por: Xiong, Yiquan, et al.
Publicado: (2017) -
Correction: Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hurthle cell carcinoma)
por: Xiong, Yiquan, et al.
Publicado: (2018) -
Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer
por: Aydemirli, Mehtap Derya, et al.
Publicado: (2019) -
Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases
por: Yang, Jing, et al.
Publicado: (2019) -
Issues in Managing Hurthle Cell Carcinoma of Thyroid: A Case Report
por: Tai, Patricia, et al.
Publicado: (2017)